Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway

Nonalcoholic fatty liver disease (NAFLD) represents one of the most common chronic liver diseases in the world. It has been reported that epigallocatechin-3-gallate (EGCG) plays important biological and pharmacological roles in mammalian cells. Nevertheless, the mechanism underlying the beneficial e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oxid Med Cell Longev
Autors principals: Wu, Dongdong, Liu, Zhengguo, Wang, Yizhen, Zhang, Qianqian, Li, Jianmei, Zhong, Peiyu, Xie, Zhongwen, Ji, Ailing, Li, Yanzhang
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8068552/
https://ncbi.nlm.nih.gov/pubmed/33953830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5599997
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars